Literature DB >> 707969

Protoporphyrin (proto)-determined hepatopathy in a South African Jewish family.

L Eales, R S Day, N R Pimstones.   

Abstract

A detailed study of a Jewish erythrohepatic protoporphyria (EHP)-affected family with a sibship consisting of 2 brothers and a sister, all of whom manifested protodetermined hepatopathy which varied from relatively mild hepatic involvement in the sister to a fulminant fatal illness in the eldest brother. The nature and course of his illness as well as the autopsy findings are described in detail. This sibship is also unique in that the 2 brothers and biochemical evidence of a severe degree of G6PD deficiency, while the sister was shown to be a carrier.

Entities:  

Mesh:

Year:  1978        PMID: 707969

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  3 in total

1.  C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.

Authors:  Sharon D Whatley; Sarah Ducamp; Laurent Gouya; Bernard Grandchamp; Carole Beaumont; Michael N Badminton; George H Elder; S Alexander Holme; Alexander V Anstey; Michelle Parker; Anne V Corrigall; Peter N Meissner; Richard J Hift; Joanne T Marsden; Yun Ma; Giorgina Mieli-Vergani; Jean-Charles Deybach; Hervé Puy
Journal:  Am J Hum Genet       Date:  2008-09-04       Impact factor: 11.025

2.  Blood exchange and transfusion therapy for acute cholestasis in protoporphyria.

Authors:  H J van Wijk; J van Hattum; H Baart de la Faille; J W van den Berg; A Edixhoven-Bosdijk; J H Wilson
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

3.  Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver.

Authors:  D L Avner; R G Lee; M M Berenson
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.